163 related articles for article (PubMed ID: 30504396)
1. Contribution of
Tsai CW; Hsu HM; Wang YC; Chang WS; Shih LC; Sun KT; Hung YW; Yang YC; Gong CL; Bau DT
Anticancer Res; 2018 Dec; 38(12):6821-6826. PubMed ID: 30504396
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Matrix Metalloproteinase-2 Promoter Genotypes to Nasopharyngeal Cancer Susceptibility and Metastasis in Taiwan.
Hsu SW; Gong CL; Hsu HM; Chao CC; Wang YC; Chang WS; Tsai YT; Shih LC; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2019; 16(4):287-292. PubMed ID: 31243109
[TBL] [Abstract][Full Text] [Related]
3. The association of matrix metalloproteinas-2 promoter polymorphisms with lung cancer susceptibility in Taiwan.
Chen GL; Wang SC; Shen TC; Tsai CW; Chang WS; Li HT; Wu CN; Chao CY; Hsia TC; Bau DT
Chin J Physiol; 2019; 62(5):210-216. PubMed ID: 31670285
[TBL] [Abstract][Full Text] [Related]
4. Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan.
Chen LH; Chiu KL; Hsia TC; Lee YH; Shen TC; Li CH; Shen YC; Chang WS; Tsai CW; Bau DT
In Vivo; 2020; 34(6):3181-3186. PubMed ID: 33144422
[TBL] [Abstract][Full Text] [Related]
5. The Contribution of Matrix Metalloproteinase-1 Genotype to Oral Cancer Susceptibility in Taiwan.
Sun KT; Tsai CW; Chang WS; Shih LC; Chen LY; Tsai MH; Ji HX; Hsiao CL; Liu YC; Li CY; Bau DT
In Vivo; 2016; 30(4):439-44. PubMed ID: 27381606
[TBL] [Abstract][Full Text] [Related]
6. Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer.
Yueh TC; Hung YC; Lee HT; Yang MD; Wang ZH; Yang YC; Ke TW; Pei JS; Tsai CW; Bau DT; Chang WS
Anticancer Res; 2022 Nov; 42(11):5335-5342. PubMed ID: 36288896
[TBL] [Abstract][Full Text] [Related]
7. The Contribution of
Yueh TC; Wu CN; Hung YW; Chang WS; Fu CK; Pei JS; Wu MH; Lai YL; Lee YM; Yen ST; Li HT; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(3):207-212. PubMed ID: 29695403
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.
Chang WS; Wang SC; Chuang CL; Ji HX; Hsiao CL; Hsu CM; Tsai CW; Liu SP; Hsu PC; Lo YL; Bau DT
Anticancer Res; 2015 Nov; 35(11):6297-301. PubMed ID: 26504066
[TBL] [Abstract][Full Text] [Related]
9. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
10. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of
Chen GL; Shen TC; Chang WS; Tsai CW; Li HT; Chuang CL; Lai YL; Yueh TC; Hsia TC; Wang SC; Bau DT
Anticancer Res; 2018 Oct; 38(10):5671-5677. PubMed ID: 30275186
[TBL] [Abstract][Full Text] [Related]
12. Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
Shih LC; Li CH; Sun KT; Chen LY; Hsu CL; Hung YW; Wu CN; Hsia TC; Shen TC; Chang WS; Shih TC; Tsai CW; Bau DT
Anticancer Res; 2018 Apr; 38(4):2087-2092. PubMed ID: 29599326
[TBL] [Abstract][Full Text] [Related]
13. Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
Shih LC; Tsai CW; Sun KT; Hsu HM; Shen TC; Tsai YT; Chang WS; Lin ML; Wang YC; Gong CL; Bau DT
In Vivo; 2019; 33(4):1151-1156. PubMed ID: 31280204
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D
Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995
[TBL] [Abstract][Full Text] [Related]
15. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility.
Hsu CF; Tseng HC; Chiu CF; Liang SY; Tsai CW; Tsai MH; Bau DT
Oral Oncol; 2009 Sep; 45(9):789-93. PubMed ID: 19217823
[TBL] [Abstract][Full Text] [Related]
16. Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Liao CH; Chang WS; Tsai CW; Hu PS; Wu HC; Hsu SW; Chen GL; Yueh TC; Shen TC; Hsia TC; Bau DT
In Vivo; 2018; 32(5):1045-1050. PubMed ID: 30388078
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk.
Hu PS; Hsia NY; Wang ZH; Chen HC; Hsia TC; Lin ML; Wang YC; Chang WS; Bau DT; Tsai CW
In Vivo; 2024; 38(2):539-545. PubMed ID: 38418145
[TBL] [Abstract][Full Text] [Related]
18. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
19. Association of
Fu CK; Mong MC; Yu CC; Yang MD; Wang ZH; Yang YC; Chen JC; Pei JS; Hsia NY; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2022 Apr; 42(4):1749-1755. PubMed ID: 35346993
[TBL] [Abstract][Full Text] [Related]
20. Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Kuo CC; Cheng SP; Tsai CW; Bau DT; Gong CL
Anticancer Res; 2019 Mar; 39(3):1185-1190. PubMed ID: 30842148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
